Index | Ligand Name | Structure | PDB code | ligand desolvation |
1 | 0ry | Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z) | 4f1l | 96.01 |
2 | ebb | Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK1 | 6fym | 94.26 |
3 | 94z | Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitor | 5nqe | 91.99 |
4 | fdr | Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a pyrimidine-like inhibitor | 3smj | 83.72 |
5 | ee5 | Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK6 | 6fzm | 76.16 |
6 | qdr | Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a quinazoline inhibitor | 3smi | 74.68 |
7 | egw | Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor MCD72 | 6g0w | 73.97 |
8 | 91j | Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one inhibitor | 5v7w | 72.57 |
9 | 0rz | Human Artd8 (Parp14, Bal2) - catalytic domain in complex with A16(E) | 4f1q | 67.98 |
10 | xl2 | Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhibitor XL2 | 4py4 | 56.16 |
11 | 91v | crystal structure of PARP14 bound to N-{4-[4-(diphenylmethoxy)piperidin-1-yl]butyl}[1,2,4]triazolo[4,3-b]pyridazin-6-amine inhibitor | 5v7t | 50.78 |
12 | 7ag | Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5 | 5lxp | 46.97 |